ONKURE THERAPEUTICS, INC. Investing Cash Flow
ONKURE THERAPEUTICS, INC. (OKUR) reported Investing Cash Flow of -$9.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-04
- ONKURE THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$9.87M.
- ONKURE THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$5.00K.
- ONKURE THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$9.00K, a 100.06% decline year-over-year.
- ONKURE THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$6.00K.
- ONKURE THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$46.00K, a 100.29% decline from fiscal 2024.
- ONKURE THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was $15.87M.
- ONKURE THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$246.00K.
- ONKURE THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$57.84M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$9.88M 10-Q · filed 2026-08-04 | -$9.88M derived: sum of 3 quarters · filed 2026-08-04 | -$9.89M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$5.00K 10-Q · filed 2026-05-05 | -$14.00K derived: sum of 2 quarters · filed 2026-05-05 | -$20.00K derived: sum of 3 quarters · filed 2026-05-05 | -$33.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$15.00K derived: sum of 2 quarters · filed 2026-03-12 | -$28.00K derived: sum of 3 quarters · filed 2026-08-04 | -$46.00K 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$19.00K derived: sum of 2 quarters · filed 2026-08-04 | -$37.00K 10-Q · filed 2025-11-06 | $15.87M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$31.00K 10-Q · filed 2026-08-04 | $15.88M derived: sum of 3 quarters · filed 2026-08-04 | $15.86M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$18.00K 10-Q · filed 2026-05-05 | $15.89M derived: sum of 2 quarters · filed 2026-05-05 | $15.87M derived: sum of 3 quarters · filed 2026-05-05 | $15.86M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $15.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $15.89M derived: sum of 2 quarters · filed 2026-03-12 | $15.88M derived: sum of 3 quarters · filed 2026-03-12 | $15.87M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$28.00K derived: sum of 2 quarters · filed 2025-11-06 | -$37.00K 10-Q · filed 2025-11-06 | $61.25M 10-Q · filed 2024-11-07 | $28.97M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$19.00K 10-Q · filed 2025-08-12 | $36.25M 10-Q · filed 2024-08-13 | $28.99M derived: sum of 3 quarters · filed 2025-08-12 | $50.24M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | -$9.00K 10-Q · filed 2025-05-06 | $13.76M 10-Q · filed 2024-05-07 | $29.00M derived: sum of 2 quarters · filed 2025-05-06 | $50.25M derived: sum of 3 quarters · filed 2025-05-06 | -$18.76M derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $29.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $50.26M derived: sum of 2 quarters · filed 2025-03-10 | -$18.75M derived: sum of 3 quarters · filed 2025-03-10 | -$246.00K 10-K · filed 2025-03-10 | $10.52M 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $21.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$47.76M derived: sum of 2 quarters · filed 2024-11-07 | -$29.25M 10-Q · filed 2024-11-07 | -$56.17M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$69.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$50.50M 10-Q · filed 2024-08-13 | -$77.42M derived: sum of 3 quarters · filed 2024-08-13 | -$122.86M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $18.51M 10-Q · filed 2024-05-07 | -$8.41M derived: sum of 2 quarters · filed 2024-05-07 | -$53.84M derived: sum of 3 quarters · filed 2024-05-07 | -$44.76M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | -$26.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$72.35M derived: sum of 2 quarters · filed 2024-03-28 | -$63.27M derived: sum of 3 quarters · filed 2024-03-28 | -$57.84M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$45.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$36.35M derived: sum of 2 quarters · filed 2023-11-13 | -$30.93M 10-Q · filed 2023-11-13 | -$22.77M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $9.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $14.51M 10-Q · filed 2023-08-10 | $22.66M derived: sum of 3 quarters · filed 2023-08-10 | $18.15M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $5.43M 10-Q · filed 2023-05-11 | $13.58M derived: sum of 2 quarters · filed 2023-05-11 | $9.07M derived: sum of 3 quarters · filed 2023-05-11 | -$17.92M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $8.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $3.64M derived: sum of 2 quarters · filed 2023-03-27 | -$23.35M derived: sum of 3 quarters · filed 2023-03-27 | -$23.38M 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | -$4.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$31.50M derived: sum of 2 quarters · filed 2022-11-08 | -$31.53M 10-Q · filed 2022-11-08 | -$31.55M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$27.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$27.02M 10-Q · filed 2022-08-09 | -$27.04M derived: sum of 3 quarters · filed 2022-08-09 | -$25.84M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$25.00K 10-Q · filed 2022-05-10 | -$41.00K derived: sum of 2 quarters · filed 2022-05-10 | $1.15M derived: sum of 3 quarters · filed 2022-05-10 | $2.15M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $1.18M derived: sum of 2 quarters · filed 2022-03-23 | $2.18M derived: sum of 3 quarters · filed 2022-03-23 | $7.38M 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.19M derived: sum of 2 quarters · filed 2021-11-12 | $7.39M 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $6.20M 10-Q · filed 2021-08-11 | ||||||
| 2020-03-31 | $5.20M 10-Q · filed 2021-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |